These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28717097)

  • 1. Plasma 2-hydroxyglutarate and hexanoylcarnitine levels are potential biomarkers for skeletal muscle toxicity in male Fischer 344 rats.
    Obayashi H; Kobayashi N; Nezu Y; Yamoto T; Shirai M; Asai F
    J Toxicol Sci; 2017; 42(4):385-396. PubMed ID: 28717097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma 2-hydroxyglutarate, a promising prognostic biomarker candidate for skeletal muscle injury in Fischer 344 rats.
    Obayashi H; Kobayashi N; Nezu Y; Yamoto T; Shirai M; Asai F
    J Toxicol Sci; 2018; 43(10):601-610. PubMed ID: 30298848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-206 as a biomarker for drug-induced skeletal muscle injury in rats.
    Yamaura Y; Kanki M; Sasaki D; Nakajima M; Unami A
    J Toxicol Sci; 2020; 45(8):503-513. PubMed ID: 32741900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats.
    Obayashi H; Nezu Y; Yokota H; Kiyosawa N; Mori K; Maeda N; Tani Y; Manabe S; Sanbuissho A
    J Toxicol Sci; 2011 Aug; 36(4):445-52. PubMed ID: 21804308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 1- and 3-methylhistidine as biomarkers of skeletal muscle toxicity by nuclear magnetic resonance-based metabolic profiling.
    Aranibar N; Vassallo JD; Rathmacher J; Stryker S; Zhang Y; Dai J; Janovitz EB; Robertson D; Reily M; Lowe-Krentz L; Lehman-McKeeman L
    Anal Biochem; 2011 Mar; 410(1):84-91. PubMed ID: 21094120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat.
    Dare TO; Davies HA; Turton JA; Lomas L; Williams TC; York MJ
    Electrophoresis; 2002 Sep; 23(18):3241-51. PubMed ID: 12298096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats.
    Schaefer WH; Lawrence JW; Loughlin AF; Stoffregen DA; Mixson LA; Dean DC; Raab CE; Yu NX; Lankas GR; Frederick CB
    Toxicol Appl Pharmacol; 2004 Jan; 194(1):10-23. PubMed ID: 14728975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Performance Evaluation of Liver and Skeletal Muscle-Specific miRNAs in Rat Plasma to Detect Drug-Induced Injury.
    Bailey WJ; Barnum JE; Erdos Z; LaFranco-Scheuch L; Lane P; Vlasakova K; Sistare FD; Glaab WE
    Toxicol Sci; 2019 Mar; 168(1):110-125. PubMed ID: 30496518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats.
    Tonomura Y; Matsushima S; Kashiwagi E; Fujisawa K; Takagi S; Nishimura Y; Fukushima R; Torii M; Matsubara M
    Toxicology; 2012 Dec; 302(2-3):179-89. PubMed ID: 22878004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the skeletal muscle injury expressed by repeated treatment with compound A that has HMG-CoA reductase inhibitory activity.
    Tanaka K; Kiyosawa N; Honda K; Sharyo S; Ito K; Teranishi M; Manabe S
    J Toxicol Sci; 2007 Feb; 32(1):9-18. PubMed ID: 17327690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity.
    Seachrist JL; Loi CM; Evans MG; Criswell KA; Rothwell CE
    Toxicol Sci; 2005 Dec; 88(2):551-61. PubMed ID: 16141437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of Novel Skeletal Muscle Biomarkers in Dogs to Drug-Induced Skeletal Muscle Injury or Sustained Endurance Exercise.
    Vlasakova K; Lane P; Michna L; Muniappa N; Sistare FD; Glaab WE
    Toxicol Sci; 2017 Apr; 156(2):422-427. PubMed ID: 28115646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats.
    Burch PM; Greg Hall D; Walker EG; Bracken W; Giovanelli R; Goldstein R; Higgs RE; King NM; Lane P; Sauer JM; Michna L; Muniappa N; Pritt ML; Vlasakova K; Watson DE; Wescott D; Zabka TS; Glaab WE
    Toxicol Sci; 2016 Mar; 150(1):247-56. PubMed ID: 26721300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker evaluation of skeletal muscle toxicity following clofibrate administration in rats.
    Bodié K; Buck WR; Pieh J; Liguori MJ; Popp A
    Exp Toxicol Pathol; 2016 May; 68(5):289-99. PubMed ID: 27020044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative morphometric study of the skeletal muscles of normal and streptozotocin-diabetic rats.
    Aughsteen AA; Khair AM; Suleiman AA
    JOP; 2006 Jul; 7(4):382-9. PubMed ID: 16832135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia.
    Wanagat J; Cao Z; Pathare P; Aiken JM
    FASEB J; 2001 Feb; 15(2):322-32. PubMed ID: 11156948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting?
    Weber MA; Kinscherf R; Krakowski-Roosen H; Aulmann M; Renk H; Künkele A; Edler L; Kauczor HU; Hildebrandt W
    J Mol Med (Berl); 2007 Aug; 85(8):887-96. PubMed ID: 17605115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the muscle toxicant 2,3,5,6-tetramethyl p-phenylenediamine: effects on various biomarkers including urinary creatine and taurine.
    Draper RP; Waterfield CJ; York MJ; Timbrell JA
    Arch Toxicol; 1994; 69(2):111-7. PubMed ID: 7717859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers.
    Pritt ML; Hall DG; Recknor J; Credille KM; Brown DD; Yumibe NP; Schultze AE; Watson DE
    Toxicol Sci; 2008 Jun; 103(2):382-96. PubMed ID: 18308699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats.
    Tonomura Y; Mori Y; Torii M; Uehara T
    Toxicology; 2009 Dec; 266(1-3):48-54. PubMed ID: 19854236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.